News | February 25, 2015

Esaote Launches Evolution'15 MRI at ECR 2015

Upgraded system enables 10-minute weight-bearing MRI protocols

Esaote, Evolution'15, MRI, ECR 2015, G-scan Brio, orthopedic imaging

February 25, 2015 — At the 2015 European Congress of Radiology (ECR 2015), Esaote introduced Evolution’15 (EVO’15) as the latest upgrade in its dedicated magnetic resonance imaging (MRI) Evolution program. EVO’15 combines software updates and new hardware features to provide high image quality and increases productivity by almost 50 percent.

Powered by eXP technology, EVO’15 is available across Esaote’s entire MRI portfolio and provides the following benefits:

  • Increased image quality for better diagnostic accuracy, due to a combination of eXP technology, graphic processing unit and X-MAR (Metal Artifact Reduction), which reduces inhomogeneity, allowing for a better evaluation of the prosthesis
  • Reduced image acquisition and reconstruction times by as much as 50 percent, thanks to Speed-Up Pro, which helps to increase throughput and minimize patient discomfort
  • Increased signal homogeneity and SNR as a result of the multichannel lumbar and cervical spine coils

By combining Speed-Up technology with GPU-based image reconstruction, the EVO’15 upgrade for Esaote’s G-scan Brio enables a very fast acquisition protocol for evaluation of spine morphology in the weight-bearing position in under 10 minutes. 

 

Other features include:

  • EVO 3D: Isotropic 3-D sequences reduce voxel size, enabling high resolution Multi-Planar Reconstruction. Used in conjunction with Speed-Up Pro, scan times are reduced by almost 50 percent
  • X-MAR: Uses new imaging sequences that increase signal to noise ratio, yet also reduce scan time. Visualization is improved using enhanced image contrast and metallic artifact reduction to reduce in-plane metal distortions (ideal for evaluating prosthesis instabilities and for post-operative patients)
  • e-Spine: Optimized spine protocols and examination management for image clarity, plus improved patient comfort and operator usability

 

EVO’15 includes brand-new multi-channel coil upgrades for performance-enhanced ergonomics and patient comfort. The advanced technology has been developed by using a low-impedance pre-amplifier, which is able to achieve a more efficient channel de-coupling for maximum signal detection.

Frieder Mauch, M.D., head of the department of shoulder and elbow surgery and MR imaging at Sportklinik Stuttgart in Germany, uses the EVO’15 upgrade with Esaote’s weight-bearing G-scan Brio: “Having two or more images showing what is happening when the patient is in different weight-bearing positions can give a better idea of the mechanical issue causing the pain. Before the EVO’15 Upgrade, this exam procedure took longer, which meant greater patient discomfort, and more movement artifacts. Now, with the EVO 3-D sequence, we can run just one steady state sequence in just one plane, and then reconstruct images in any other plane using the MPR (Multi Planar Reconstruction) features. This makes for a full weight-bearing exam in less than 10 minutes.”

For more information: www.esaote.com

Related Content

ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
Canon Medical Introduces Encore Orian MR Upgrade Program
News | Magnetic Resonance Imaging (MRI) | August 06, 2019
Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...